Antibiotic Prophylaxis for Dental Procedures in High‑Risk Cardiac Patients

Dosing Recommendations (ACC/AHA)

Adults – oral amoxicillin: 2 g given as a single dose 30–60 minutes before the dental procedure. 1
Adults – parenteral alternative when oral not possible: 2 g ampicillin IM or IV within 30 minutes before the procedure. 1
Adults – second‑line parenteral alternative: 1 g cefazolin or ceftriaxone IM or IV within 30 minutes before the procedure (avoid in patients with severe penicillin allergy). 1
Children (≥3 months) – oral amoxicillin: 50 mg/kg as a single dose (maximum 2 g) 30–60 minutes before the procedure. 1
Children – parenteral alternative when oral not possible: 50 mg/kg ampicillin IM or IV within 30 minutes before the procedure. 1
Children – second‑line parenteral alternative: 50 mg/kg cefazolin or ceftriaxone IM or IV within 30 minutes before the procedure (avoid in severe penicillin allergy). 5

Oral cephalexin: 2 g for adults, 50 mg/kg for children (first‑ or second‑generation cephalosporin). 1
Oral clindamycin: 600 mg for adults, 20 mg/kg for children. 1
Oral azithromycin or clarithromycin: 500 mg for adults, 15 mg/kg for children. 1
Parenteral cefazolin/ceftriaxone: 1 g for adults, 50 mg/kg for children (use only if no immediate‑type hypersensitivity to penicillins). 1
Parenteral clindamycin: 600 mg for adults, 20 mg/kg for children. 1
Contraindication: Cephalosporins must not be used in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins or ampicillin. 1

High‑risk cardiac conditions merit prophylaxis only when dental procedures involve manipulation of gingival tissue, the periapical region of teeth, or perforation of oral mucosa (including routine cleaning when bleeding is expected). 1

Prosthetic cardiac valve or prosthetic material used for valve repair. 1
Prior infective endocarditis. 1
Unrepaired cyanotic congenital heart disease (including palliative shunts or conduits). 1
Completely repaired congenital heart disease with prosthetic material/device, within the first 6 months after surgery or catheter intervention. 1
Repaired congenital heart disease with residual defects adjacent to a prosthetic patch or device. 1
Cardiac transplant recipients who develop valvulopathy. 1

Any dental intervention that manipulates gingival tissue, the periapical region, or perforates oral mucosa, as well as routine cleanings when bleeding is anticipated. 1

Renal impairment (hemodialysis or chronic kidney disease): The standard single oral dose of 2 g amoxicillin given 1 hour before the procedure requires no dose adjustment; administer before dialysis when feasible. 7
Penicillin‑allergic patients on dialysis: 600 mg clindamycin orally 1 hour before the procedure. 7
Nephrotoxic agents: Aminoglycosides and tetracyclines should be avoided in patients with chronic kidney disease due to nephrotoxicity. 7

The 2007 ACC/AHA guidelines narrowed prophylaxis because daily activities (e.g., chewing, tooth brushing) generate more bacteremia than dental procedures; prophylaxis prevents only a very small number of endocarditis cases, and the risk of antibiotic‑related adverse effects may outweigh any benefit. 1

Current resistance among viridans streptococci: 13–50 % to penicillin, 22–58 % to macrolides, and 13–27 % to clindamycin. Despite this, amoxicillin remains the preferred agent because of its excellent oral absorption and sustained serum concentrations. 2

The 2009 European Society of Cardiology (ESC) recommendations mirror ACC/AHA dosing: amoxicillin 2 g oral/IV for adults and 50 mg/kg for children; clindamycin 600 mg (adults) or 20 mg/kg (children) for penicillin‑allergic patients. 4

Do not prescribe prophylaxis for isolated mitral valve prolapse, bicuspid aortic valve, or calcific aortic stenosis—these are not high‑risk conditions. 4
Do not use prophylaxis for gastrointestinal or genitourinary procedures to prevent endocarditis. 1
Do not exceed the adult dose when treating obese children; the pediatric dose is capped at the adult maximum. 5
Do not administer cephalosporins to patients with immediate‑type hypersensitivity reactions to penicillins. 1